Outcome of acute myeloid leukemia (AML) relapsing after autologous bone marrow transplantation (ABMT) in first remission.

被引：0
|
作者：
Vignetti, M
Iacopino, P
Trasarti, S
Messina, G
Barbui, T
Carella, AM
Alessandrino, PP
Benedetti, F
Falda, M
Sajeva, MT
Carlo-Stella, C
Lambertenghi, G
Sica, S
Visani, G
Meloni, G
机构：
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
13
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] Autologous bone marrow transplant (ABMT) for acute myelogenous leukemia (AML) in second or subsequent remission.
    Califaretti, N
    Davidson, M
    Abraham, R
    Roitman, D
    Crump, M
    Keating, A
    BLOOD, 1998, 92 (10) : 294A - 294A
  • [2] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOBLASTIC-LEUKEMIA (AML) IN REMISSION
    MELONI, G
    DEFABRITIIS, P
    PULSONI, A
    SANDRELLI, A
    SIMONE, F
    PETTI, MC
    MANDELLI, F
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 244 - 245
  • [3] Malignant karyotype predicts outcome after but not before autologous bone marrow transplantation (ABMT) in transplant candidates with acute myeloid leukemia (AML)
    Imrie, K
    Prince, HM
    Dube, I
    Crump, M
    Stewart, AK
    Keating, A
    BLOOD, 1995, 86 (10) : 157 - 157
  • [4] Autologous stem cell transplantation for acute myeloid leukemia in first remission.
    Linker, CA
    Ries, CA
    Damon, LE
    Rugo, HS
    Topolsky, D
    Crilley, P
    Brodsky, I
    Rubin, A
    Case, D
    BLOOD, 1995, 86 (10) : 384 - 384
  • [5] Autologous stem cell transplantation for acute myeloid leukemia in first remission.
    Linker, CA
    Ries, CA
    Damon, LE
    Rugo, HS
    Wolf, JL
    Topolsky, D
    Crilley, P
    Brodsky, I
    Rubin, A
    Case, D
    Zamkoff, K
    BLOOD, 1997, 90 (10) : 493 - 493
  • [6] Autologous stem cell transplantation for acute myeloid leukemia in first remission.
    Linker, CA
    Ries, CA
    Damon, LE
    Wolf, JL
    Topolsky, D
    Crilley, P
    Brodsky, I
    Rubin, A
    Case, D
    Zamkoff, K
    BLOOD, 1999, 94 (10) : 579A - 579A
  • [7] Scoring system to predict the outcome after autologous stern cell transplantation for acute myeloid leukemia in first remission.
    Sierra, J
    Esteve, T
    Canals, C
    Lahuerta, JJ
    Conde, E
    Carrera, D
    Figuera, A
    Tormo, M
    Díaz-Mediavilla, J
    Martín, C
    Forés, R
    Vidal, MJ
    De Pablos, J
    Parody, R
    Cañizo, C
    Bueno, J
    Ribera, JM
    Moraleda, JM
    Díez, JL
    Odriozola, J
    Brunet, S
    De la Serna, J
    Rovira, M
    Sanz, MA
    BLOOD, 2002, 100 (11) : 218A - 218A
  • [8] Meta-analysis of autologous bone marrow transplantation (ABMT) vs. chemotherapy in adult patients with AML in first remission.
    Levi, I
    Grotto, I
    Yerushalmi, R
    Ben-Bassat, I
    Shpilberg, O
    BLOOD, 2001, 98 (11) : 202B - 202B
  • [9] Treatment with low dose IL-2 after autologous bone marrow transplantation (ABMT) for acute myeloid leukemia (AML)
    Falkenburg, JHF
    Schaafsma, MR
    Smith, WM
    KluinNelemans, JC
    HooftmandenOtter, A
    Rijnbeek, M
    vandeMarel, A
    Schellekens, M
    Brandely, M
    Fibbe, WE
    Willemze, R
    BLOOD, 1995, 86 (10) : 2252 - 2252
  • [10] Allogeneic and autologous bone marrow transplantation in AML in first remission. The Spanish experience.
    Ortega, JJ
    Olive, T
    deHeredia, CD
    Coll, MT
    Bastida, P
    Massuet, L
    BONE MARROW TRANSPLANTATION, 1996, 18 : 53 - 58
12345